Abraham, Bincy
Eksteen, Bertus
Nedd, Khan
Kale, Hrishikesh
Patel, Dipen
Stephens, Jennifer
Shelbaya, Ahmed
Chambers, Richard
Soonasra, Arif
Clinical trials referenced in this document:
Documents that mention this clinical trial
Impact of Infliximab-dyyb (Infliximab Biosimilar) on Clinical and Patient-Reported Outcomes: 1-Year Follow-up Results from an Observational Real-World Study Among Patients with Inflammatory Bowel Disease in the US and Canada (the ONWARD Study)
https://doi.org/10.1007/s12325-022-02104-6
Funding for this research was provided by:
Pfizer
Article History
Received: 17 February 2022
Accepted: 22 February 2022
First Online: 16 March 2022